Le Lézard
Classified in: Covid-19 virus
Subjects: Conference, Product/Service, Trade Show

CEIR Breaking News: 2022 CEIR Index Report Now Available


Today, the Center for Exhibition Industry Research (CEIR) released the 2022 CEIR Index Report, which analyzes the 2021 business-to-business (B2B) exhibition industry performance and provides an economic and exhibition industry forecast for the next three years.

"Between 2019 and today, the relevance of the CEIR Index Report is evident," said CEIR CEO Cathy Breden, CMP-F, CAE, CEM. "The economic impact figures greatly helped in supporting messaging to business media and in communicating the value of the exhibitions industry to our elected officials. As the industry continues to recover, we will be able to provide valuable insights comparing performance pre-pandemic to current day, and sectors poised to recover with those sectors that will face challenges."

"Nothing tells the story of the business-to-business exhibitions industry like the CEIR Index Report," added Tommy Goodwin, Vice President of Government Affairs for the Exhibitions & Conferences Alliance (ECA). "The Index is the foundation of the advocacy story that ECA shares with policymakers in Washington, D.C. and across the country about how our industry drives economic growth, puts people to work, and supports small businesses nationwide."

The CEIR Index Report provides data on the U.S. B2B exhibition industry across 14 key sectors. As an objective measure of the annual performance of the exhibition industry, the CEIR Index measures year-over-year changes in four key metrics to determine overall performance: net square feet (NSF) of exhibit space sold; professional attendance; number of exhibiting companies; and gross revenue. The 14 industry sectors are:

A forecast update of the CEIR Index Report will be presented at the CEIR Predict conference on 15-16 September 2022 at the MGM National Harbor in Oxon Hill, Md. This year's conference examine the impact of the pandemic on the exhibition industry, and possible scenarios for the next three years.

"In the baseline scenario, impact of COVID-19 diminishes and the exhibition industry should see a dramatic rebound in 2022, exceeding 100 percent year-over-year increases in almost all 14 sectors, albeit from a low base in 2021," said CEIR Economist Dr. Allen Shaw, Chief Economist for Global Economic Consulting Associates, Inc. "By the end of 2023, the exhibition industry is expected to fully recover. Nonetheless, performance by sector will diverge depending on its secular (long-term) trends and underlying macroeconomic conditions."

Click here to purchase the 2022 CEIR Index Report and/or individual sector reports.

CEIR appreciates the support for the Index Report from 2022 Predict partners:

Collaborator
Freeman
GES
Orange County Convention Center
Synchronicities
Visit Dallas
Visit Orlando

Associate
Fern
mdg, A Freeman Company

Contributor
CORT Events
Las Vegas Convention & Visitors Authority
Los Angeles Tourism & Convention Board
Map Your Show
Maritz Global Events
MGM Resorts International
New Orleans & Company
Oscar & Associates
TVS

About CEIR

The Center for Exhibition Industry Research (CEIR) serves to advance the growth, awareness and value of exhibitions and other face-to-face marketing events by producing and delivering knowledge-based research tools that enable stakeholder organizations to enhance their ability to meet current and emerging customer needs, improve their business performance and strengthen their competitive position. For additional information, visit www.ceir.org.


These press releases may also interest you

at 11:40
The "Global Needle Coke Market: Focus on Application, Type, Grade, End Use, and Country-Level Analysis - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering. The global needle coke market was valued at $3.05...

at 11:15
Expomed Eurasia, the most important medical exhibition between Europe and Asia, is ready to house more than a hundred companies, to discover new technological trends and the most innovative products which are going to change deeply the health market....

at 11:15
Nora Pharma, a Canadian pharmaceutical company, has received approval for its first Biosimilar product. Nora Pharma, a wholly owned division of Sunshine Biopharma, has received approval from Health Canada for the commercialization of NIOPEG® (a...

at 09:35
Two large multi-state studies uncovered a highly effective way to improve antibiotic selection for patients hospitalized with pneumonia or urinary tract infections (UTI), enabling better antibiotic stewardship in hospitals, according to research...

at 09:25
The "The U.S. Telehealth Weight Loss Market" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering The report includes in-depth analyses of: the scope of telehealth usage in the U.S., telehealth user demographics, pros and...

at 09:00
Amid growing concerns about a medical crisis as a result of acute conflict between the government...



News published on and distributed by: